• In July 2026, Campbell's Company launched Campbell's Protein Soups, a five-flavor line featuring slow-simmered bone broth, 20 grams of protein per can, and a green-label design, now rolling out nationwide at US$3.19.
• This launch targets the large group of Americans actively seeking more protein and balanced nutrition, aligning Campbell's traditional soup expertise with modern wellness-focused eating habits.
• We'll now explore how this protein-focused innovation, aimed at health-conscious consumers, could influence Campbell's broader investment narrative.

Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

Campbell's Investment Narrative Recap

To own Campbell’s, you need to believe its core soups, sauces, and snacks can stay relevant while margins hold up despite cost and volume pressures. The new Protein Soups line fits the health and wellness catalyst, but on its own it does not materially change the near term risk that higher input costs and slower category growth could keep earnings under pressure.

The most relevant recent development alongside Protein Soups is the June partnership with Banza to launch a gluten free condensed soup. Together, these launches highlight Campbell’s focus on health oriented innovation as a potential offset to volume stagnation in traditional canned soups, a key catalyst if they can support pricing and mix without relying solely on cost cuts.

But even with new protein products on shelves, investors should still be aware of how rising input costs and shifting tastes could...

Campbell's narrative projects $10.4 billion revenue and $895.6 million earnings by 2029. This requires 1.5% yearly revenue growth and a roughly $287.6 million earnings increase from $608.0 million today.

Uncover how Campbell's forecasts yield a $21.47 fair value, in line with its current price.

Exploring Other Perspectives

Compared with consensus, the most pessimistic analysts saw 2029 earnings slipping to about US$541.8 million with flat revenue, which contrasts sharply with the idea that innovation like Protein Soups can lift growth. Their view reminds you that expectations differ widely and that new products may or may not shift a story that some already expect to weaken.

Explore 6 other fair value estimates on Campbell's - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Campbell's research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Campbell's research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Campbell's overall financial health at a glance.

Looking For Alternative Opportunities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Find 38 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.